Capillary Biomedical

07/21/2022

We are excited to be joining the Tandem Diabetes Care family!

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today announced its acquisition of infusion set developer, Capillary Biomedical.

04/03/2019

Our updated inserter design.

Never see the insertion needle or movement and sharp safe for reduced worry and easy disposal.

08/16/2018

https://www.businesswire.com/news/home/20180814005564/en/Capillary-Biomedical-Closes-2.9-Million-Series-Seed

Capillary Biomedical has raised $2.9 million in series seed funding for its innovative new insulin infusion technology.

08/15/2018

Detailed writeup on our progress here.

https://www.closeconcerns.com/knowledgebase/r/f375d542

07/14/2018

Headed home from FFL early tomorrow. Exhausted and energized at the same time. Huge thanks to those who gave their time and shared their voices to help us make a batter infusion set. I am blown away.

06/03/2018

We're looking forward to our focus groups at the Friends for Life Conference
http://signup.com/go/WJyHLhT

04/26/2018

http://markets.businessinsider.com/news/stocks/finalists-announced-for-2018-diabetes-innovation-challengewinners-of-250-000-in-cash-and-in-kind-prizes-to-be-announced-at-live-event-in-boston-may-21-1022115725

BOSTON, April 24, 2018 (GLOBE NEWSWIRE) -- T1D Exchange, a nonprofit patient-centered research organization dedicated to accelerating novel treatments to ...

04/24/2018

Winners of $250,000 in Cash and In-Kind Prizes to be Announced at Live Event in Boston May 21

04/18/2018

Honored to be selected as semi-finalists in the Diabetes Innovation Challenge by T1D Exchange! Register and vote for our Kink-Proof Infusion entry!

A global competition. A world of good.Which innovation stands to improve the lives of those affected by diabetes? You decide. Voting begins March 23, 2018.

03/21/2018